Top 5: The Pandemic's Influence On Biologic Drug Substance Outsourcing Risk Mitigation
Source: ISR Reports
In Q4 2020, ISR asked 110 outsourcers of biologic drug substance about how the pandemic has influenced their risk mitigation strategies with regards to outsourcing. The most popular response is to increase contingency planning (54%). Just over one-third of respondents (38%) plan to increase inventory / stock up, and 36% intend to revisit disaster planning.
access the Infographic!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
ISR Reports
This website uses cookies to ensure you get the best experience on our website. Learn more